25 February 2025
Health Care Law Today
GLP-1 Receptor Agonists: New Frontiers and Challenges
Recently, a new class of drugs, based on GLP-1, are revolutionizing medicine and the treatment of patients with diabetes, obesity, and other disorders associated with obesity.